caffeine has been researched along with Lung Diseases in 13 studies
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the benefits and harms of doxapram administration on the incidence of apnea and other short-term and longer-term clinical outcomes in preterm infants." | 9.41 | Doxapram for the prevention and treatment of apnea in preterm infants. ( Avdic, E; Bruschettini, M; Evans, S; Fiander, M; Pessano, S; Soll, R, 2023) |
| " Although methylxanthines are widely used to prevent and treat apnea associated with prematurity and to facilitate extubation, there is uncertainty about the benefits and harms of different types of methylxanthines." | 9.41 | Methylxanthine for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Davis, PG; Fiander, M; Marques, KA; Roehr, CC; Soll, R, 2023) |
| "To evaluate the benefits and harms of doxapram administration on the incidence of apnea and other short-term and longer-term clinical outcomes in preterm infants." | 5.41 | Doxapram for the prevention and treatment of apnea in preterm infants. ( Avdic, E; Bruschettini, M; Evans, S; Fiander, M; Pessano, S; Soll, R, 2023) |
| " Although methylxanthines are widely used to prevent and treat apnea associated with prematurity and to facilitate extubation, there is uncertainty about the benefits and harms of different types of methylxanthines." | 5.41 | Methylxanthine for the prevention and treatment of apnea in preterm infants. ( Bruschettini, M; Davis, PG; Fiander, M; Marques, KA; Roehr, CC; Soll, R, 2023) |
| "Findings of lung granulomas are not rare but their etiology may be embarrassing in autoptic and especially in bioptic material which is shown in two such cases: a 19-year old drug addict man practising intravenous administration of Alnagon pills and a 54-year old woman working with acrylonitrile fibres." | 3.68 | [Granulomatous processes in the lungs]. ( Dĕdic, K; Horácek, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, S | 1 |
| Avdic, E | 1 |
| Pessano, S | 1 |
| Fiander, M | 2 |
| Soll, R | 2 |
| Bruschettini, M | 2 |
| Marques, KA | 1 |
| Roehr, CC | 1 |
| Davis, PG | 1 |
| Picarillo, AP | 1 |
| Carlo, W | 1 |
| Alur, P | 1 |
| Bollampalli, V | 1 |
| Bell, T | 1 |
| Hussain, N | 1 |
| Liss, J | 1 |
| CUSSINI, G | 1 |
| GALLIANI, A | 1 |
| MENGUY, R | 2 |
| Baldwin, DN | 1 |
| Pillow, JJ | 1 |
| Stocks, J | 1 |
| Frey, U | 1 |
| Daly, JW | 1 |
| Lefton-Greif, MA | 1 |
| McGrath-Morrow, SA | 1 |
| Murphy, MG | 1 |
| Peck, CC | 1 |
| Conner, DP | 1 |
| Zamani, K | 1 |
| Merenstein, GB | 1 |
| Rodden, D | 1 |
| Horácek, J | 1 |
| Dĕdic, K | 1 |
| Boyd, EM | 1 |
| Hottenroth, SM | 1 |
6 reviews available for caffeine and Lung Diseases
| Article | Year |
|---|---|
Doxapram for the prevention and treatment of apnea in preterm infants.
Topics: Aminophylline; Apnea; Caffeine; Doxapram; Humans; Infant, Newborn; Infant, Premature; Lung Diseases | 2023 |
Methylxanthine for the prevention and treatment of apnea in preterm infants.
Topics: Apnea; Caffeine; Cerebral Palsy; Disabled Persons; Humans; Infant; Infant, Newborn; Infant, Prematur | 2023 |
Using Quality Improvement Tools to Reduce Chronic Lung Disease.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Caffeine; Chronic Disease; Continuous Positive | 2017 |
CURRENT CONCEPTS OF THE ETIOLOGY OF DUODENAL ULCER.
Topics: Adrenal Cortex Hormones; Aspirin; Caffeine; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Genetics, | 1964 |
Lung-function tests in neonates and infants with chronic lung disease: tidal breathing and respiratory control.
Topics: Adult; Animals; Caffeine; Central Nervous System Stimulants; Chemoreceptor Cells; Chronic Disease; F | 2006 |
Caffeine analogs: biomedical impact.
Topics: Alzheimer Disease; Asthma; Biomedical Research; Caffeine; Calcium; Central Nervous System Stimulants | 2007 |
7 other studies available for caffeine and Lung Diseases
| Article | Year |
|---|---|
Serum caffeine concentrations and short-term outcomes in premature infants of ⩽29 weeks of gestation.
Topics: Caffeine; Chronic Disease; Gestational Age; Hospital Charges; Humans; Infant, Premature; Length of S | 2015 |
[Chronic bronchopneumopathy in young and old smokers: therapeutic effectiveness of a multivalent drug].
Topics: Antipyrine; Bronchi; Bronchial Diseases; Caffeine; Digitalis; Digitalis Glycosides; Disease; Lung Di | 1962 |
[ETIOLOGY OF THE DUODENAL ULCER].
Topics: Aspirin; Caffeine; Disease Susceptibility; Duodenal Ulcer; Genetics, Medical; Humans; Hyperparathyro | 1964 |
Deglutition and respiration: development, coordination, and practical implications.
Topics: Bronchopulmonary Dysplasia; Caffeine; Child, Preschool; Chlorpheniramine; Codeine; Deglutition Disor | 2007 |
Transcutaneous theophylline collection in preterm infants.
Topics: Age Factors; Caffeine; Diffusion; Humans; Infant, Newborn; Infant, Premature; Lung Diseases; Methods | 1990 |
[Granulomatous processes in the lungs].
Topics: Acrylonitrile; Adult; Aspirin; Caffeine; Codeine; Drug Combinations; Female; Granuloma; Humans; Lung | 1990 |
The toxicity of phenacetin at the range of the oral LD50(100 days) in albino rats.
Topics: Animals; Asthenia; Ataxia; Caffeine; Chemical and Drug Induced Liver Injury; Cyanosis; Dehydration; | 1968 |